Editorial: Novel preclinical model, biomarker, treatment and drug delivery to address immune evasion in cancer

被引：0
|
作者：
Mai, Chun-Wai [1 ]
Jilkova, Zuzana Macek [2 ,3 ]
Dua, Kamal [4 ,5 ]
Goh, Bey-Hing [6 ,7 ]
机构：
[1] UCSI Univ, Fac Pharmaceut Sci, Kuala Lumpur, Malaysia
[2] Univ Grenoble Alpes, Inst Adv Biosci, CNRS, UMR 5309,INSERM U 1209, Grenoble, France
[3] Univ Hosp Grenoble, Dept Hepatogastroenterol & Digest Oncol, Grenoble, France
[4] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW, Australia
[5] Univ Technol Sydney, Fac Hlth, Australian Res Ctr Complementary & Integrat Med, Ultimo, NSW, Australia
[6] Sunway Univ Malaysia, Sunway Biofunct Mol Discovery Ctr, Sch Med & Life Sci, Bandar Sunway, Selangor, Malaysia
[7] Monash Univ Malaysia, Sch Pharm, Biofunct Mol Exploratory Res Grp, Bandar Sunway, Selangor, Malaysia
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词：
cancer immunology; cancer; modeling; biomarker; treatment;
D O I：
10.3389/fimmu.2024.1486819
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Preclinical imaging for targeting cancer immune evasion
    Terlizzi, Cristina
    De Rosa, Viviana
    Iommelli, Francesca
    Altobelli, Giovanna G.
    Fonti, Rosa
    Del Vecchio, Silvana
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 64 (02): : 186 - 193
  • [2] Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion
    Huang, Peng
    Wang, Jie
    Yu, Zongze
    Lu, Jiaan
    Sun, Zhou
    Chen, Zhigui
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] Autophagy in cancer development, immune evasion, and drug resistance
    Niu, Xuegang
    You, Qi
    Hou, Kaijian
    Tian, Yu
    Wei, Penghui
    Zhu, Yang
    Gao, Bin
    Ashrafizadeh, Milad
    Aref, Amir Reza
    Kalbasi, Alireza
    Canadas, Israel
    Sethi, Gautam
    Tergaonkar, Vinay
    Wang, Lingzhi
    Lin, Yuanxiang
    Kang, Dezhi
    Klionsky, Daniel J.
    DRUG RESISTANCE UPDATES, 2025, 78
  • [4] New intra-arterial drug delivery system for the treatment of liver cancer: Preclinical assessment in a rabbit model of liver cancer
    Hong, K
    Khwaja, A
    Liapi, E
    Torbenson, MS
    Georgiades, CS
    Geschwind, JFH
    CLINICAL CANCER RESEARCH, 2006, 12 (08) : 2563 - 2567
  • [5] The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates
    Liuyue Kan
    Ying Yu
    Yaxue Wang
    Lei Shi
    Tingyuan Fan
    Hui Chen
    Chuanli Ren
    Molecular Cancer, 24 (1)
  • [6] Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms
    Guo, Jinhui
    Zhao, Jie
    Fu, Wen
    Xu, Qiuran
    Huang, Dongsheng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer
    Saha, Ivy
    Halder, Jitu
    Rajwar, Tushar Kanti
    Mahanty, Ritu
    Pradhan, Deepak
    Dash, Priyanka
    Das, Chandan
    Rai, Vineet Kumar
    Kar, Biswakanth
    Ghosh, Goutam
    Rath, Goutam
    AAPS PHARMSCITECH, 2024, 25 (04)
  • [8] SPARC is a Novel Prognostic Biomarker for Ovarian Cancer and Associated with Immune Signatures and Drug Response
    Guo, Xiaorong
    Tai, Huilin
    Li, Xiaoqing
    Liu, Peng
    Liu, Jin
    Yu, Shan
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (03):
  • [9] A Novel Preclinical In Vitro 3D Model of Oral Carcinogenesis for Biomarker Discovery and Drug Testing
    Suryaprakash, Ravi Teja Chitturi
    Shearston, Kate
    Farah, Camile S.
    Fox, Simon A.
    Iqbal, Muhammad Munir
    Kadolsky, Ulrich
    Zhong, Xiao
    Saxena, Alka
    Kujan, Omar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [10] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer
    Boumelha, Jesse
    de Carne, Sophie
    Romero, Pablo
    Moliona, Miriam
    Downward, Julian
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
12345